GGrantIndex
Sort

64,565 grants matching drug discovery

Transport across two membranes by AcrAB-TolC

$493,878
Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2022 · AI

Sorted libraries of error-free long oligonucleotides

$493,877
Jean-Marie Rouillard · Biodiscovery, Llc · R44 · FY2014 · GM

Transport across two membranes by AcrAB-TolC

$493,833
Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2021 · AI

High-Throughput Platform for Identifying Stem Cell Toxicity

$493,806
Jonathan S. Dordick · Rensselaer Polytechnic Institute · R01 · FY2013 · ES

Process and pathway based discovery of novel anti-TB drugs

$493,771
David Alland · Rbhs-New Jersey Medical School · U19 · FY2017 · AI

Leadership, Planning, and Evaluation

$493,758
Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2023 · CA

Leadership, Planning, and Evaluation

$493,758
Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2022 · CA

Leadership, Planning, and Evaluation

$493,755
Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2024 · CA

Transforming Translational Science and Education to Benefit Human Health

$493,737
Barry Coller · Rockefeller University · UL1 · FY2011 · RR

Diagnostic Tools for Targeted Heart Failure Treatments

$493,728
Tetsuro Wakatsuki · Invivosciences, Inc. · R43 · FY2022 · HL

Inhibitors of protein-protein interactions

$493,663
Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Protein Structure, Stability, and Amyloid Formation

$493,654
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Metalloproteinases in Tumor Progression and Metastasis

$493,651
Burnham Institute For Medical Research · R01 · FY2005 · CA

CD24 as Therapeutic Target for Multiple Sclerosis-phase II Competing Renewal

$493,610
Dexing Fang · Oncoimmune, Inc. · R44 · FY2010 · NS

Discovery and Validation of Drug Targets in Vulnerable Populations

$493,607
David Alland · Rbhs-New Jersey Medical School · R33 · FY2016 · AI

Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development

$493,556
Mark Y Chiang · University Of Michigan At Ann Arbor · R01 · FY2023 · AI

Estrogen receptor mediated reprogramming of prostate in BPH

$493,543
Paul S Cooke · University Of Florida · R01 · FY2019 · DK

Estrogen receptor mediated reprogramming of prostate in BPH

$493,543
Paul S Cooke · University Of Florida · R01 · FY2020 · DK

Experimental and Computational Models of Bacteria Transport and Adhesion in the Microvasculature

$493,499
Bahareh Behkam · Virginia Polytechnic Institute And State University · · FY2021 · ENG

Developmental Funds

$493,464
Jennifer A Pietenpol · Vanderbilt University · P30 · FY2011 · CA

Cell biology of vasopressin-induced water channels

$493,453
Dennis Brown · Massachusetts General Hospital · R01 · FY2012 · DK

Discover Small Molecule Chemical Probes to Modulate RING-type E3 Ubiquitin Ligases

$493,449
Zhen-Qiang Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · GM

Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis

$493,341
Russell Alfred Debose-Boyd · Ut Southwestern Medical Center · R01 · FY2021 · GM

Small molecule probes of cytokinesis

$493,335
Ulrike S Eggert · Dana-Farber Cancer Inst · R01 · FY2009 · GM

In Vitro and In Situ Engineering of Fibroblasts for Cardiac Repair

$493,302
Nenad Bursac · Duke University · R01 · FY2016 · HL